|
1
|
Arber DA, Orazi A, Hasserjian R, Thiele J,
Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M and Vardiman JW:
The 2016 revision to the World Health Organization classification
of myeloid neoplasms and acute leukemia. Blood. 127:2391–2405.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grimwade D, Biondi A, Mozziconacci MJ,
Hagemeijer A, Berger R, Neat M, Howe K, Dastugue N, Jansen J,
Radford-Weiss I, et al: Characterization of acute promyelocytic
leukemia cases lacking the classic t(15;17): Results of the
european working party. Groupe français de cytogénétique
hématologique, groupe de français d'hematologie cellulaire, UK
cancer cytogenetics group and BIOMED 1 european community-concerted
action ‘molecular cytogenetic diagnosis in haematological
malignancies’. Blood. 96:1297–1308. 2000.PubMed/NCBI
|
|
3
|
Chen WX, Zhu HL, Xue M, Zhou H, Zhao F,
Yan N and Chen Y: Quick staining technique for myeloperoxidase
using potassium iodide and oxidized pyronine B. Acta Histochem.
116:292–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gale RE, Hills R, Pizzey AR, Kottaridis
PD, Swirsky D, Gilkes AF, Nugent E, Mills KI, Wheatley K, Solomon
E, et al: Relationship between FLT3 mutation status, biologic
characteristics, and response to targeted therapy in acute
promyelocytic leukemia. Blood. 106:3768–3776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Montesinos P and Sanz MA: The
differentiation syndrome in patients with acute promyelocytic
leukemia: Experience of the pethema group and review of the
literature. Mediterr J Hematol Infect Dis. 3:e20110592011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Ma J, Liu X, Liu R, Xu L, Wang L,
Cen J and Chu X: A complex translocation (3;17;15) in acute
promyelocytic leukemia confirmed by fluorescence in situ
hybridization. Oncol Lett. 12:4717–4719. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang R, Kim YM, Wang X, Li Y, Pang H, Lee
JY and Li S: Coexistence of t(15;17) and t(15;16;17) detected by
fluorescence in situ hybridization in a patient with acute
promyelocytic leukemia: A case report and literature review. Oncol
Lett. 8:1001–1008. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bennour A, Tabka I, Youssef YB, Zaier M,
Hizem S, Khelif A, Saad A and Sennana H: A PML/RARA chimeric gene
on chromosome 12 in a patient with acute promyelocytic leukemia
(M4) associated with a new variant translocation:
t(12;15;17)(q24;q24;q11). Med Oncol. 30:4092013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Osella P, Wyandt H, Vosburgh E and
Milunsky A: Report of a variant t(1;15;17)(p36;q22;q21.1) in a
patient with acute promyelocytic leukemia. Cancer Genet Cytogenet.
57:201–207. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park JP and Fairweather RB: Complex
t(1;15;17) in acute promyelocytic leukemia with duplication of RAR
alpha and PML sequences. Cancer Genet Cytogenet. 89:52–56. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Galieni P, Marotta G, Vessichelli F,
Diverio D, Minoletti F, Bucalossi A, Lo Coco F and Lauria F:
Variant t(1;15;17)(q23;q22;q23) in a case of acute promyelocytic
leukemia. Leukemia. 10:1658–1661. 1996.PubMed/NCBI
|
|
12
|
Miyazaki K, Kikukawa M, Kiuchi A, Shin K,
Iwamoto T and Ohyashiki K: Complex translocations derived stepwise
from standard t(15;17) in a patient with variant acute
promyelocytic leukemia. Cancer Genet Cytogenet. 176:127–130. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y and Rowley JD: Chromatin
structural elements and chromosomal translocations in leukemia. DNA
Repair (Amst). 5:1282–1297. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tse W, Zhu W, Chen HS and Cohen A: A novel
gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically
expressed in leukemic and immature hematopoietic cells. Blood.
85:650–656. 1995.PubMed/NCBI
|
|
15
|
Busson-Le Coniat M, Salomon-Nguyen F,
Hillion J, Bernard OA and Berger R: MLL-AF1q fusion resulting from
t(1;11) in acute leukemia. Leukemia. 13:302–306. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nguyen TT, Ma LN, Slovak ML, Bangs CD,
Cherry AM and Arber DA: Identification of novel Runx1 (AML1)
translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute
myeloid leukemia. Genes Chromosomes Cancer. 45:918–932. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Beitinjaneh A, Jang S, Roukoz H and
Majhail NS: Prognostic significance of FLT3 internal tandem
duplication and tyrosine kinase domain mutations in acute
promyelocytic leukemia: A systematic review. Leuk Res. 34:831–836.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Souza Melo CP, Campos CB, Dutra ÁP, Neto
JC, Fenelon AJ, Neto AH, Carbone EK, Pianovski MA, Ferreira AC and
Assumpcão JG: Correlation between FLT3-ITD status and clinical,
cellular and molecular profiles in promyelocytic acute leukemias.
Leuk Res. 39:131–137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lucena-Araujo AR, Kim HT, Jacomo RH, Melo
RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille
Mde L, Chiattone CS, et al: Internal tandem duplication of the FLT3
gene confers poor overall survival in patients with acute
promyelocytic leukemia treated with all-trans retinoic acid and
anthracycline-based chemotherapy: An International Consortium on
Acute Promyelocytic Leukemia study. Ann Hematol. 93:2001–2010.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poiré X, Moser BK, Gallagher RE, Laumann
K, Bloomfield CD, Powell BL, Koval G, Gulati K, Holowka N, Larson
RA, et al: Arsenic trioxide in front-line therapy of acute
promyelocytic leukemia (C9710): Prognostic significance of FLT3
mutations and complex karyotype. Leuk Lymphoma. 55:1523–1532. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cicconi L, Divona M, Ciardi C, Ottone T,
Ferrantini A, Lavorgna S, Alfonso V, Paoloni F, Piciocchi A,
Avvisati G, et al: PML-RARα kinetics and impact of FLT3-ITD
mutations in newly diagnosed acute promyelocytic leukaemia treated
with ATRA and ATO or ATRA and chemotherapy. Leukemia. 30:1987–1992.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wiernik PH, Sun Z, Gundacker H, Dewald G,
Slovak ML, Paietta E, Kim HT, Appelbaum FR, Cassileth PA and
Tallman MS: Prognostic implications of additional chromosome
abnormalities among patients with de novo acute promyelocytic
leukemia with t(15;17). Med Oncol. 29:2095–2101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fujishima M, Takahashi N, Miura I,
Kobayashi Y, Kume M, Nishinari T and Miura AB: A PML/RARA chimeric
gene on chromosome 2 in a patient with acute promyelocytic leukemia
(M3) associated with a new variant translocation:
t(2;15;17)(q21;q22;q21). Cancer Genet Cytogenet. 120:80–82. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hernández JM, Martín G, Gutiérrez NC,
Cervera J, Ferro MT, Calasanz MJ, Martínez-Climent JA, Luño E,
Tormo M, Rayón C, et al: Additional cytogenetic changes do not
influence the outcome of patients with newly diagnosed acute
promyelocytic leukemia treated with an ATRA plus anthracyclin based
protocol. A report of the Spanish group PETHEMA. Haematologica.
86:807–813. 2001.PubMed/NCBI
|
|
25
|
De Botton S, Chevret S, Sanz M, Dombret H,
Thomas X, Guerci A, Fey M, Rayon C, Huguet F, Sotto JJ, et al:
Additional chromosomal abnormalities in patients with acute
promyelocytic leukaemia (APL) do not confer poor prognosis: Results
of APL 93 trial. Br J Haematol. 111:801–806. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
de Botton S, Coiteux V, Chevret S, Rayon
C, Vilmer E, Sanz M, de La Serna J, Philippe N, Baruchel A,
Leverger G, et al: Outcome of childhood acute promyelocytic
leukemia with all-trans-retinoic acid and chemotherapy. J Clin
Oncol. 22:1404–1412. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Freeman CE, Mercer DD, Ye Y, Van Brunt J
III and Li MM: Cytogenetic and molecular characterization of
complex three-way translocations in acute promyelocytic leukemia.
Beijing Da Xue Xue Bao Yi Xue Ban. 41:477–479. 2009.PubMed/NCBI
|
|
28
|
McKinney CD, Golden WL, Gemma NW, Swerdlow
SH and Williams ME: RARA and PML gene rearrangements in acute
promyelocytic leukemia with complex translocations and atypical
features. Genes Chromosomes Cancer. 9:49–56. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Calabrese G, Min T, Stuppia L, Powles R,
Swansbury JG, Morizio E, Peila R, Donti E, Fioritoni G and Palka G:
Complex chromosome translocations of standard t(8;21) and t(15;17)
arise from a two-step mechanism as evidenced by fluorescence in
situ hybridization analysis. Cancer Genet Cytogenet. 91:40–45.
1996. View Article : Google Scholar : PubMed/NCBI
|
